Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: A multicentre, open-label, phase 2 trial

Arun Rajan, Corey A. Carter, Arlene Berman, Liang Cao, Ronan J. Kelly, Anish Thomas, Sean Khozin, Ariel Lopez Chavez, Isabella Bergagnini, Barbara Scepura, Eva Szabo, Min Jung Lee, Jane B. Trepel, Sarah K. Browne, Lindsey B. Rosen, Yunkai Yu, Seth M. Steinberg, Helen X. Chen, Gregory J. Riely, Giuseppe Giaccone

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: A multicentre, open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences